Amanda is a member of our Life Sciences patent team. Some areas in which Amanda has particular expertise include:
Amanda has a PhD in Neuroscience from University College London (2012); her Doctoral research focused on developing cell therapies for ocular degenerative disorders.
As a research fellow both at the University of Cambridge and Harvard University, Amanda has substantial research experience developing gene therapies for the treatment of ophthalmological degenerative disorders.
Amanda joined Mewburn Ellis LLP in 2018.